Emerging evidence suggested that MSCs-Exo could inhibit liver fibrosis by multiple processes, including autophagy, TGF-β/smad, Wnt/β-catenin, LPS/TLR4, EMT/ERK1, PPARγ, NF-κB pathway [43]. The gene discussed is MAPK3; the disease is Hepatic fibrosis.